Systematic Review| Volume 29, ISSUE 12, P2037-2048, December 2013

The Efficacy of Platelet-Rich Plasma in the Treatment of Symptomatic Knee Osteoarthritis: A Systematic Review With Quantitative Synthesis


      The purpose of this systematic review was to synthesize the available Level I and Level II literature on platelet-rich plasma (PRP) as a therapeutic intervention in the management of symptomatic knee osteoarthritis (OA).


      A systematic review of Medline, Embase, Cochrane Central Register of Controlled Trials, PubMed, and was performed to identify all randomized controlled trials and prospective cohort studies that evaluated the clinical efficacy of PRP versus a control injection for knee OA. A random-effects model was used to evaluate the therapeutic effect of PRP at 24 weeks by use of validated outcome measures (Western Ontario and McMaster Universities Arthritis Index, visual analog scale for pain, International Knee Documentation Committee Subjective Knee Evaluation Form, and overall patient satisfaction).


      Six Level I and II studies satisfied our inclusion criteria (4 randomized controlled trials and 2 prospective nonrandomized studies). A total of 577 patients were included, with 264 patients (45.8%) in the treatment group (PRP) and 313 patients (54.2%) in the control group (hyaluronic acid [HA] or normal saline solution [NS]). The mean age of patients receiving PRP was 56.1 years (51.5% male patients) compared with 57.1 years (49.5% male patients) for the group receiving HA or NS. Pooled results using the Western Ontario and McMaster Universities Arthritis Index scale (4 studies) showed that PRP was significantly better than HA or NS injections (mean difference, −18.0 [95% confidence interval, −28.8 to −8.3]; P < .001). Similarly, the International Knee Documentation Committee scores (3 studies) favored PRP as a treatment modality (mean difference, 7.9 [95% confidence interval, 3.7 to 12.1]; P < .001). There was no difference in the pooled results for visual analog scale score or overall patient satisfaction. Adverse events occurred more frequently in patients treated with PRP than in those treated with HA/placebo (8.4% v 3.8%, P = .002).


      As compared with HA or NS injection, multiple sequential intra-articular PRP injections may have beneficial effects in the treatment of adult patients with mild to moderate knee OA at approximately 6 months. There appears to be an increased incidence of nonspecific adverse events among patients treated with PRP.

      Level of evidence

      Level II, systematic review of Level I and II studies.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Arthroscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Richmond J.
        • Hunter D.
        • Irrgang J.
        • et al.
        American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis (OA) of the knee.
        J Bone Joint Surg Am. 2010; 92: 990-993
        • Rankin E.A.
        • Alarcon G.S.
        • Chang R.W.
        • et al.
        NIH consensus statement on total knee replacement December 8-10, 2003.
        J Bone Joint Surg Am. 2004; 86: 1328-1335
        • Maricar N.
        • Callaghan M.J.
        • Felson D.T.
        • O'Neill T.W.
        Predictors of response to intra-articular steroid injections in knee osteoarthritis—A systematic review.
        Rheumatology. 2013; 52: 1022-1032
        • Bellamy N.
        • Campbell J.
        • Robinson V.
        • Gee T.
        • Bourne R.
        • Wells G.
        Viscosupplementation for the treatment of osteoarthritis of the knee.
        Cochrane Database Syst Rev. 2006; : CD005321
        • Brouwer R.W.
        • Jakma T.S.C.
        • Verhagen A.P.
        • Verhaar J.A.N.
        • Bierma-Zeinstra S.M.A.
        Braces and orthoses for treating osteoarthritis of the knee.
        Cochrane Database Syst Rev. 2005; : CD004020
        • Fransen M.
        • McConnell S.
        Exercise for osteoarthritis of the knee.
        Cochrane Database Syst Rev. 2008; : CD004376
        • Nuesch E.
        • Rutjes A.W.S.
        • Husni E.
        • Welch V.
        • Juni P.
        Oral or transdermal opioids for osteoarthritis of the knee or hip.
        Cochrane Database Syst Rev. 2009; : CD003115
        • Towheed T.E.
        • Maxwell L.
        • Anastassiades T.P.
        • et al.
        Glucosamine therapy for treating osteoarthritis.
        Cochrane Database Syst Rev. 2005; : CD002946
        • Wandel S.
        • Juni P.
        • Tendal B.
        • et al.
        Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: Network meta-analysis.
        BMJ. 2010; 341: c4675
        • Moreland L.W.
        Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: Mechanisms of action.
        Arthritis Res Ther. 2003; 5: 54-67
        • Brief A.A.
        • Maurer S.G.
        • Di Cesare P.E.
        Use of glucosamine and chondroitin sulfate in the management of osteoarthritis.
        J Am Acad Surg. 2001; 9: 71-78
        • Kirkley A.
        • Birmingham T.B.
        • Litchfield R.B.
        • et al.
        A randomized trial of arthroscopic surgery for osteoarthritis of the knee.
        N Engl J Med. 2008; 359: 1097-1107
        • Katz J.N.
        • Brophy R.H.
        • Chaisson C.E.
        • et al.
        Surgery versus physical therapy for a meniscal tear and osteoarthritis.
        N Engl J Med. 2013; 368: 1675-1684
        • Laupaffarakasem W.
        • Laopaiboon M.
        • Laupattarakasem P.
        • Sumananont C.
        Arthroscopic debridement for knee osteoarthritis.
        Cochrane Database Syst Rev. 2008; : CD005118
        • Brouwer R.W.
        • Raaij van T.M.
        • Bierma-Zeinstra S.M.
        • Verhagen A.P.
        • Jakma T.S.
        • Verhaar J.A.
        Osteotomy for treating knee osteoarthritis.
        Cochrane Database Syst Rev. 2007; : CD004019
        • Balazs E.A.
        Analgesic effect of elastoviscous hyaluronan solutions and the treatment of arthritic pain.
        Cells Tissues Organs. 2003; 174: 49-62
        • Cerza F.
        • Carni S.
        • Carcangiu A.
        • et al.
        Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis.
        Am J Sports Med. 2012; 40: 2822-2827
        • Strauss E.J.
        • Hart J.A.
        • Miller M.D.
        • Altman R.D.
        • Rosen J.E.
        Hyaluronic acid viscosupplementation and osteoarthritis: Current uses and future directions.
        Am J Sports Med. 2009; 37: 1636-1644
        • Kaplan L.D.
        • Lu Y.
        • Snitzer J.
        • et al.
        The effect of early hyaluronic acid delivery on the development of an acute articular cartilage lesion in a sheep model.
        Am J Sports Med. 2009; 37: 2323-2327
        • Saw K.Y.
        • Hussin P.
        • Loke S.C.
        • et al.
        Articular cartilage regeneration with autologous marrow aspirate and hyaluronic acid: An experimental study in a goat model.
        Arthroscopy. 2009; 25: 1391-1400
        • Miyakoshi N.
        • Kobayashi M.
        • Nozaka K.
        • Okada K.
        • Shimada Y.
        • Itoi E.
        Effects of intraarticular administration of basic fibroblast growth factor with hyaluronic acid on osteochondral defects of the knee in rabbits.
        Arch Orthop Trauma Surg. 2005; 125: 683-692
        • Kon E.
        • Mandelbaum B.
        • Buda R.
        • et al.
        Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis.
        Arthroscopy. 2011; 27: 1490-1501
        • Juni P.
        • Reichenbach S.
        • Trelle S.
        • et al.
        Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee—A randomized controlled trial.
        Arthritis Rheum. 2007; 56: 3610-3619
        • Baltzer A.W.A.
        • Moser C.
        • Jansen S.A.
        • Krauspe R.
        Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis.
        Osteoarthritis Cartilage. 2009; 17: 152-160
        • Bernstein J.
        Therapeutic effects of hyaluronic acid on osteoarthritis of the knee.
        J Bone Joint Surg Am. 2004; 86 (2567)
        • Ghosh P.
        • Guidolin D.
        Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: Are the effects molecular weight dependent?.
        Semin Arthritis Rheum. 2002; 32: 10-37
        • Mihara M.
        • Higo S.
        • Uchiyama Y.
        • Tanabe K.
        • Saito K.
        Different effects of high molecular weight sodium hyaluronate and NSAID on the progression of the cartilage degeneration in rabbit OA model.
        Osteoarthritis Cartilage. 2007; 15: 543-549
        • Curran M.P.
        Hyaluronic acid (Supartz): A review of its use in osteoarthritis of the knee.
        Drugs Aging. 2010; 27: 925-941
        • Marx R.E.
        Platelet-rich plasma (PRP): What is PRP and what is not PRP?.
        Implant Dent. 2001; 10: 225-228
        • Eppley B.L.
        • Woodell J.E.
        • Higgins J.
        Platelet quantification and growth factor analysis from platelet-rich plasma: Implications for wound healing.
        Plast Reconstr Surg. 2004; 114: 1502-1508
        • Paoloni J.
        • De Vos R.J.
        • Hamilton B.
        • Murrell G.A.
        • Orchard J.
        Platelet-rich plasma treatment for ligament and tendon injuries.
        Clin J Sport Med. 2011; 21: 37-45
        • Taylor D.W.
        • Petrera M.
        • Hendry M.
        • Theodoropoulos J.S.
        A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries.
        Clin J Sport Med. 2011; 21: 344-352
        • Steinert A.F.
        • Middleton K.K.
        • Araujo P.H.
        • Fu F.H.
        Platelet-rich plasma in orthopaedic surgery and sports medicine: Pearls, pitfalls, and new trends in research.
        Oper Tech Orthop. 2012; 22: 91-103
        • Nguyen R.T.
        • Borg-Stein J.
        • McInnis K.
        Applications of platelet-rich plasma in musculoskeletal and sports medicine: An evidence-based approach.
        PM R. 2011; 3: 226-250
        • Sheth U.
        • Simunovic N.
        • Klein G.
        • et al.
        Efficacy of autologous platelet-rich plasma use for orthopaedic indications: A meta-analysis.
        J Bone Joint Surg Am. 2012; 94: 298-307
        • Patel S.
        • Dhillon M.S.
        • Aggarwal S.
        • Marwaha N.
        • Jain A.
        Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: A prospective, double-blind, randomized trial.
        Am J Sports Med. 2013; 41: 356-364
        • Wright J.G.
        • Swiontkowski M.F.
        • Heckman J.D.
        Introducing levels of evidence to the journal.
        J Bone Joint Surg Am. 2003; 85: 1-3
        • Hulley S.B.
        • Cummings S.R.
        • Browner W.S.
        • Grady D.
        • Newman T.B.
        Designing clinical research.
        Ed 3. Lippincott Williams & Wilkins, Philadelphia2006
        • Kellgren J.H.
        • Lawrence J.S.
        Radiological assessment of osteo-arthrosis.
        Ann Rheum Dis. 1957; 16: 494-502
        • Ahlbäck S.
        Osteoarthrosis of the knee. A radiographic investigation.
        Acta Radiol Diagn (Stockh). 1968; : 7-72
        • Filardo G.
        • Kon E.
        • Di Martino A.
        • et al.
        Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: Study design and preliminary results of a randomized controlled trial.
        BMC Musculoskel Dis. 2012; 13: 229
        • Li M.
        • Zhang C.
        • Ai Z.
        • Yuan T.
        • Feng Y.
        • Jia W.
        Therapeutic effectiveness of intra-knee-articular injection of platelet-rich plasma on knee articular cartilage degeneration.
        Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2011; 25 (in Chinese): 1192-1196
        • Spakova T.
        • Rosocha J.
        • Lacko M.
        • Harvanova D.
        • Gharaibeh A.
        Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid.
        Am J Phys Med Rehabil. 2012; 91: 411-417
        • Bellamy N.
        • Buchanan W.W.
        • Goldsmith C.H.
        • Campbell J.
        • Stitt L.W.
        Validation-study of WOMAC—A health-status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug-therapy in patients with osteo-arthritis of the hip or knee.
        J Rheumatol. 1988; 15: 1833-1840
        • McConnell S.
        • Kolopack P.
        • Davis A.M.
        The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): A review of its utility and measurement properties.
        Arthritis Rheum. 2001; 45: 453-461
        • Flandry F.
        • Hunt J.P.
        • Terry G.C.
        • Hughston J.C.
        Analysis of subjective knee complaints using visual analog scales.
        Am J Sports Med. 1991; 19: 112-118
        • Price D.D.
        • McGrath P.A.
        • Rafii A.
        • Buckingham B.
        The validation of visual analog scales as ratio scale measures for chronic and experimental pain.
        Pain. 1983; 17: 45-56
        • Higgins L.D.
        • Taylor M.K.
        • Park D.
        • et al.
        Reliability and validity of the International Knee Documentation Committee (IKDC) Subjective Knee Form.
        Joint Bone Spine. 2007; 74: 594-599
        • Sanchez M.
        • Fiz N.
        • Azofra J.
        • et al.
        A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis.
        Arthroscopy. 2012; 28: 1070-1078
        • Detsky A.S.
        • Naylor C.D.
        • Orourke K.
        • McGeer A.J.
        • Labbe K.A.
        Incorporating variations in the quality of individual randomized trials into metaanalysis.
        J Clin Epidemiol. 1992; 45: 255-265
      1. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. Available from: Accessed March 15, 2013.

        • Chahal J.
        • Van Thiel G.S.
        • Mall N.
        • et al.
        The role of platelet-rich plasma in arthroscopic rotator cuff repair: A systematic review with quantitative synthesis.
        Arthroscopy. 2012; 28: 1718-1727
        • Higgins J.P.T.
        • Thompson S.G.
        • Deeks J.J.
        • Altman D.G.
        Measuring inconsistency in meta-analyses.
        BMJ. 2003; 327: 557-560
        • Higgins J.P.T.
        • Thompson S.G.
        Quantifying heterogeneity in a meta-analysis.
        Stat Med. 2002; 21: 1539-1558
        • Collins N.J.
        • Misra D.
        • Felson D.T.
        • Crossley K.M.
        • Roos E.M.
        Measures of knee function: International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Knee Outcome Survey Activities of Daily Living Scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Activity Rating Scale (ARS), and Tegner Activity Score (TAS).
        Arthritis Care Res (Hoboken). 2011; 63: S208-S228
        • Rogers J.C.
        • Irrgang J.J.
        Measures of adult lower extremity function: The American Academy of Orthopedic Surgeons Lower Limb Questionnaire, The Activities of Daily Living Scale of the Knee Outcome Survey (ADLS), Foot Function Index (FFI), Functional Assessment System (FAS), Harris Hip Score (HHS), Index of Severity for Hip Osteoarthritis (ISH), Index of Severity for Knee Osteoarthritis (ISK), Knee Injury and Osteoarthritis Outcome Score (KOOS), and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).
        Arthritis Care Res (Hoboken). 2003; 49: S67-S84
        • Park S.I.
        • Lee H.R.
        • Kim S.
        • Ahn M.W.
        • Do S.H.
        Time-sequential modulation in expression of growth factors from platelet-rich plasma (PRP) on the chondrocyte cultures.
        Mol Cell Biochem. 2012; 361: 9-17
        • Wu C.C.
        • Chen W.H.
        • Zao B.
        • et al.
        Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis.
        Biomaterials. 2011; 32: 5847-5854
        • Spreafico A.
        • Chellini F.
        • Frediani B.
        • et al.
        Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes.
        J Cell Biochem. 2009; 108: 1153-1165
        • Mishra A.
        • Tummala P.
        • King A.
        • et al.
        Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation.
        Tissue Eng Part C Methods. 2009; 15: 431-435
        • Zaky S.H.
        • Ottonello A.
        • Strada P.
        • Cancedda R.
        • Mastrogiacomo M.
        Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering.
        J Tissue Eng Regen Med. 2008; 2: 472-481
        • Akeda K.
        • An H.S.
        • Okuma M.
        • et al.
        Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis.
        Osteoarthritis Cartilage. 2006; 14: 1272-1280
        • Drengk A.
        • Zapf A.
        • Sturmer E.K.
        • Sturmer K.M.
        • Frosch K.H.
        Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells.
        Cells Tissues Organs. 2009; 189: 317-326
        • Pettersson S.
        • Wettero J.
        • Tengvall P.
        • Kratz G.
        Human articular chondrocytes on macroporous gelatin microcarriers form structurally stable constructs with blood-derived biological glues in vitro.
        J Tissue Eng Regen Med. 2009; 3: 450-460
        • van Buul G.M.
        • Koevoet W.L.
        • Kops N.
        • et al.
        Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes.
        Am J Sports Med. 2011; 39: 2362-2370
        • Bendinelli P.
        • Matteucci E.
        • Dogliotti G.
        • et al.
        Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: Mechanisms of NF-kappaB inhibition via HGF.
        J Cell Physiol. 2010; 225: 757-766
        • Milano G.
        • Deriu L.
        • Sanna Passino E.
        • et al.
        Repeated platelet concentrate injections enhance reparative response of microfractures in the treatment of chondral defects of the knee: An experimental study in an animal model.
        Arthroscopy. 2012; 28: 688-701
        • Milano G.
        • Sanna Passino E.
        • Deriu L.
        • et al.
        The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: An experimental study in a sheep model.
        Osteoarthritis Cartilage. 2010; 18: 971-980
        • Saito M.
        • Takahashi K.A.
        • Arai Y.
        • et al.
        Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee.
        Clin Exp Rheumatol. 2009; 27: 201-207
        • Qi Y.Y.
        • Chen X.
        • Jiang Y.Z.
        • et al.
        Local delivery of autologous platelet in collagen matrix simulated in situ articular cartilage repair.
        Cell Transplant. 2009; 18: 1161-1169
        • Sun Y.
        • Feng Y.
        • Zhang C.Q.
        • Chen S.B.
        • Cheng X.G.
        The regenerative effect of platelet-rich plasma on healing in large osteochondral defects.
        Int Orthop. 2010; 34: 589-597
        • Lippross S.
        • Moeller B.
        • Haas H.
        • et al.
        Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint.
        Arthritis Rheum. 2011; 63: 3344-3353
        • Kruger J.P.
        • Hondke S.
        • Endres M.
        • Pruss A.
        • Siclari A.
        • Kaps C.
        Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells.
        J Orthop Res. 2012; 30: 845-852
        • Doucet C.
        • Ernou I.
        • Zhang Y.
        • et al.
        Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications.
        J Cell Physiol. 2005; 205: 228-236
        • Weibrich G.
        • Kleis W.K.
        • Hafner G.
        • Hitzler W.E.
        • Wagner W.
        Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank.
        Clin Oral Implants Res. 2003; 14: 357-362
        • Harrison P.
        • Cramer E.M.
        Platelet alpha-granules.
        Blood Rev. 1993; 7: 52-62
        • van den Dolder J.
        • Mooren R.
        • Vloon A.P.
        • Stoelinga P.J.
        • Jansen J.A.
        Platelet-rich plasma: Quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells.
        Tissue Eng. 2006; 12: 3067-3073
        • Cho H.S.
        • Song I.H.
        • Park S.Y.
        • Sung M.C.
        • Ahn M.W.
        • Song K.E.
        Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells.
        Korean J Lab Med. 2011; 31: 212-218
        • Kasten P.
        • Vogel J.
        • Beyen I.
        • et al.
        Effect of platelet-rich plasma on the in vitro proliferation and osteogenic differentiation of human mesenchymal stem cells on distinct calcium phosphate scaffolds: The specific surface area makes a difference.
        J Biomater Appl. 2008; 23: 169-188
        • Vogel J.P.
        • Szalay K.
        • Geiger F.
        • Kramer M.
        • Richter W.
        • Kasten P.
        Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics.
        Platelets. 2006; 17: 462-469
        • Lin S.S.
        • Landesberg R.
        • Chin H.S.
        • Lin J.
        • Eisig S.B.
        • Lu H.H.
        Controlled release of PRP-derived growth factors promotes osteogenic differentiation of human mesenchymal stem cells.
        Conf Proc IEEE Eng Med Biol Soc. 2006; 1: 4358-4361
        • Kasten P.
        • Vogel J.
        • Luginbühl R.
        • et al.
        Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics.
        Cells Tissues Organs. 2006; 183: 68-79
        • Goedecke A.
        • Wobus M.
        • Krech M.
        • et al.
        Differential effect of platelet-rich plasma and fetal calf serum on bone marrow-derived human mesenchymal stromal cells expanded in vitro.
        J Tissue Eng Regen Med. 2011; 5: 648-654
        • Mifune Y.
        • Matsumoto T.
        • Takayama K.
        • et al.
        The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair.
        Osteoarthritis Cartilage. 2013; 21: 175-185
        • Kasten P.
        • Vogel J.
        • Geiger F.
        • Niemeyer P.
        • Luginbuhl R.
        • Szalay K.
        The effect of platelet-rich plasma on healing in critical-size long-bone defects.
        Biomaterials. 2008; 29: 3983-3992
        • Niemeyer P.
        • Fechner K.
        • Milz S.
        • et al.
        Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma.
        Biomaterials. 2010; 31: 3572-3579
        • Noth U.
        • Rackwitz L.
        • Heymer A.
        • et al.
        Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels.
        J Biomed Mater Res Part A. 2007; 83: 626-635
        • Schmidt M.B.
        • Chen E.H.
        • Lynch S.E.
        A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair.
        Osteoarthritis Cartilage. 2006; 14: 403-412
        • Engebretsen L.
        • Steffen K.
        • Alsousou J.
        • et al.
        IOC consensus paper on the use of platelet-rich plasma in sports medicine.
        Br J Sports Med. 2010; 44: 1072-1081
        • Weinstein J.N.
        • Tosteson T.D.
        • Lurie J.D.
        • et al.
        Surgical vs nonoperative treatment for lumbar disk herniation—The Spine Patient Outcomes Research Trial (SPORT): A randomized trial.
        JAMA. 2006; 296: 2441-2450